SCHEMBL19089429

SCHEMBL19089429

CC(C)Nc1ccc(Cl)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.50
IDO1 P14902 1/20 0.42
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 2/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
RECQL P46063 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TRPA1 O75762 1/20 0.38
KDM4E B2RXH2 1/20 0.38
BCL6 P41182 1/20 0.38
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL631778 0.84 TSHR (0.53) RAPGEF4MAPTTSHRLMNAALDH1A1
SCHEMBL6071981 0.81 ALDH1A1 (0.47) RAPGEF4MAPTTDP1TSHRLMNA
SCHEMBL633387 0.81 MMP8 (0.53) RAPGEF4IDO1MAPTTDP1TSHR
SCHEMBL24681299 0.80 RAPGEF4 (0.44) RAPGEF4IDO1MAPTMAPK1TDP1
SCHEMBL11599210 0.79 RAPGEF4 (0.43) RAPGEF4IDO1TSHRLMNAKDM4E
SCHEMBL11599212 0.79 RAPGEF4 (0.43) RAPGEF4IDO1TSHRLMNAKDM4E
SCHEMBL12368476 0.78 TDP1 (0.41) RAPGEF4IDO1TDP1TSHRLMNA
SCHEMBL14268251 0.78 ALDH1A1 (0.44) RAPGEF4MAPTTDP1TSHRLMNA
SCHEMBL31757629 0.77 RAPGEF4 (0.55) RAPGEF4IDO1MAPTMAPK1ALDH1A1
SCHEMBL2093509 0.77 RAPGEF4 (0.55) RAPGEF4IDO1MAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10342796-B2 Acrylanilide derivative, preparation method, and applications thereof in pharmacy ANCUREALL PHARMACEUTICAL (SHANGHAI) CO., LTD. (CN) 2019-07-09 US disclosed
US-20190015413-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD, AND APPLICATIONS THEREOF IN PHARMACY ANCUREALL PHARMACEUTICAL (SHANGHAI) CO., LTD. (CN) 2019-01-17 US disclosed
WO-2017114500-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY 恩瑞生物医药科技(上海)有限公司 2017-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10342796-B2 Acrylanilide derivative, preparation method, and applications thereof in pharmacy EGFR, ABL1, CSNK1A1 RAPGEF4 3021/4885IDO1 3839/4885MAPT 1913/4885
US-20190015413-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD, AND APPLICATIONS THEREOF IN PHARMACY EGFR, ABL1, CSNK1A1 RAPGEF4 3021/4885IDO1 3839/4885MAPT 1913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.